Drugs Made In America Acquisition Corp. amended a merger agreement with Power Analytics Global Corp. to allow for a standalone business combination closing at a lower valuation if the target company fails to acquire APQC Inc. by Nov. 1. The amendment addresses the withdrawal of a previous financial opinion and establishes a new valuation standard for the transaction.